3 Biggest Pharmaceutical Companies in the World

3. Novartis (NYSE:NVS)

Switzerland makes its entry now, as Novartis, one of the most recognized global names in pharma, has made its presence felt on a global level, with revenue of $47 billion and net income of $12.2 billion. Despite its profitability, hedge funds tracked by Insider Monkey don’t believe Novartis is a great stock to buy. We track more than 800 hedge funds and only 21 of these hedge funds had a bullish position in Novartis at the end of June.

Hedge funds’ bullish Novartis positions stood at 30 at the end of March. This means at least 9 hedge funds sold their entire stake in Novartis during the second quarter. Billionaires Ken Fisher and Jim Simons‘ funds each had more than $700 million in NVS,

2. Roche (OTC:RHHBY)

Two Swiss companies appear in quick succession, as Roche is one of only two pharma companies in the world which actually has revenues exceeding $50 billion, while its net income is $13.6 billion. Since Roche shares aren’t listed in any of the major US exchanges, we have no idea about hedge fund interest in this pharmaceutical giant.

On the next page you can find the most profitable pharmaceutical company in the world.